betaxolol has been researched along with Glioma in 2 studies
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MacEwan, DJ | 1 |
Milligan, G | 1 |
Hough, C | 1 |
Chuang, DM | 1 |
2 other studies available for betaxolol and Glioma
Article | Year |
---|---|
Inverse agonist-induced up-regulation of the human beta2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Betaxolol; Glioma; GTP-Binding | 1996 |
Differential down-regulation of beta 1- and beta 2-adrenergic receptor mRNA in C6 glioma cells.
Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Cell Division; Down-Regulation; Glioma; Isoproteren | 1990 |